Bettzy Stephen
The University of Texas MD Anderson Cancer Center · 142 works · 1,911 citations · h-index 20
Top works
- Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study
- Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience
- Survival of 1,181 Patients in a Phase I Clinic: The MD Anderson Clinical Center for Targeted Therapy Experience
- Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma
- Phase 2 study of pembrolizumab in patients with advanced rare cancers
- TP53 Alterations Correlate with Response to VEGF/VEGFR Inhibitors: Implications for Targeted Therapeutics
- Radiomics to predict immunotherapy-induced pneumonitis: proof of concept
- 2 Conceiving The Research Question
- Thymoma Patients Treated in a Phase I Clinic at MD Anderson Cancer Center: Responses to mTOR Inhibitors and Molecular Analyses
- Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience
- Pembrolizumab for advanced penile cancer: a case series from a phase II basket trial
- Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trial
- Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers
- The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial
- Revisiting Clinical Trials Using EGFR Inhibitor-Based Regimens in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis of an MD Anderson Cancer Center Phase I Population
- Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study
- Haplotype Analysis of the T-Cell Receptor Beta (TCRB) Locus by Long-amplicon TCRB Repertoire Sequencing
- Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas
- Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experience
- Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial